NeurAxis, Inc. (NRXS)

NYSEAMERICAN: NRXS · USD

$7.37

+0.01 (+0.1%)· Recorded snapshot

Market cap	92.6M
Revenue (ttm)	5.3M
Net income (ttm)	-8.5M
EPS (ttm)	-$0.78
Shares out	12.6M
Volume	71,349
Beta	1.36

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.3M
Net income (ttm): -8.5M
EPS (ttm): -$0.78
Market cap: 92.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-139.8

P25 -113.8P50 -46.5P75 -0.9

ROIC-82.2

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All NRXS indicators

Market & fundamental data

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001933567
Company name	NeurAxis, Inc.
Country	United States
Country code	US
CUSIP number	64134X201
Earnings date	2026-11-09
Earnings time	bmo
Employees	24
Employees change	3
Employees growth	14.29%
Enterprise value	$84.5M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2011
Industry	Biotechnology
IPO date	2023-08-09
Is primary listing	Yes
Is SPAC	No
ISIN number	US64134X2018
Last 10-K release date	2026-03-19
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$92.6M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$7.37
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	NRXS
U.S. state	Indiana
Website	https://neuraxis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-10.52%
EV/Sales	16.09x
FCF / EV yield	-6.59%
FCF yield	-6.02%
Forward EV/Sales	7.07x
Forward P/S	7.73x
P/B ratio	13.63x
P/S ratio	17.6x
Price / tangible book value	14.45x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-144.51%
EBITDA margin	-143.13%
Gross margin	85.56%
Operating margin	-144.51%
Pretax margin	-144.44%
Profit margin	-144.44%
Profit per employee	$-352,213
Revenue per employee	$221,505
ROA	-56.21%
ROA (5Y)	-192.35%
ROCE	-111.34%
ROE	-139.76%
ROIC	-82.23%
SBC / revenue	26.09%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	5
EPS growth years	2
Gross profit growth	67.35%
Gross profit growth (Q)	121.57%
Gross profit growth 3Y	24.16%
Net income growth years	0
Revenue growth	65.22%
Revenue growth (Q)	115.72%
Revenue growth (QoQ)	19.95%
Revenue growth 3Y	25.6%
Revenue growth quarters	8
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-12,165
Depreciation and amortization	$73,228
EBIT	$-7.7M
EBITDA	$-7.6M
EPS	$-0.78
FCF per share	$-0.45
Financing cash flow	$8.1M
Free cash flow	$-5.6M
Free cash flow minus SBC	$-7M
Gross profit	$4.5M
Investing cash flow	$-112,165
Net borrowing	$-242,345
Net cash flow	$2.3M
Net income	$-8.5M
Operating cash flow minus SBC	$-7M
Operating income	$-7.7M
Revenue	$5.3M
Stock-based compensation	$1.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.77
Book value per share	$0.54
Debt / equity	0.04
Interest coverage	-73.67
Long-term assets	$582,015
Long-term liabilities	$164,724
Net cash (debt)	$8M
Net cash / market cap	8.6%
Net cash growth	44.19%
Net debt / equity	-1.19
Piotroski F-Score	3
Property, plant and equipment	$294,008
Shareholders' equity	$6.7M
Tangible book value	$6.5M
Tangible book value per share	$0.52
Total assets	$10M
Total cash	$8.3M
Total debt	$279,392
Total liabilities	$3.3M
WACC	11.81%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.62
Current assets	$9.4M
Current liabilities	$3.1M
Current ratio	3.04
Inventory turnover	3.76
Net working capital	$-1.9M
Quick ratio	2.83
Working capital	$6.3M
Working capital turnover	1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-46.92%
Dividend yield	0%
Shareholder yield	-46.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$7.03
1D price change	0.14%
1M price change	-0.13%
1M total return	-0.13%
1W price change	-3.45%
1W total return	-3.45%
1Y price change	142.77%
1Y return CAGR	142.91%
1Y total return	142.77%
20-day SMA	$7.23
200-day SMA	$6.64
3M price change	12.02%
3M total return	12.02%
3Y price change	259.52%
3Y return CAGR	53.18%
3Y total return	259.51%
50-day SMA	$6.79
50-day SMA vs 200-day SMA	50over200
52-week high	$9.33
52-week high date	2026-05-05
52-week low	$2.21
52-week low date	2025-11-20
6M price change	-7.13%
6M total return	-7.13%
All-time high	$9.33
All-time high date	2026-05-05
All-time low	$1.33
All-time low date	2025-04-16
Average true range (ATR)	$0.46
Average volume	141.6K
Beta (1Y)	0.25
Beta (2Y)	0.9
Beta (5Y)	1.36
Change from 52-week high	-21.01%
Change from 52-week low	233.48%
Change from all-time high	-19.08%
Change from all-time low	467.67%
Change from open	1.52%
Day's gap	-1.36%
Dollar volume	$525,842
High price	$7.41
Low price	$7.26
Monthly RSI	66.9
Open price	$7.26
Position in 52-week range	73.33%
Premarket change	-0.14%
Premarket close	$7.36
Premarket price	$7.35
Premarket volume	424
Previous close	$7.36
Price vs 150-day SMA	7.35%
Price vs 20-day SMA	4.37%
Price vs 200-day SMA	13.67%
Price vs 50-day SMA	11.14%
Relative volume	0.5
Return from IPO open	18.25%
Return from IPO price	24.17%
RSI	56.12
Sharpe ratio	1.51
Sharpe ratio (3Y)	0.73
Sortino ratio	2.71
Sortino ratio (3Y)	1.39
Volume	71.3K
Weekly RSI	57.83
YTD price change	66.3%
YTD total return	66.3%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8.3M
Float percentage	66.35%
Shares change (QoQ)	10.7%
Shares change (YoY)	46.92%
Shares held by insiders	30.55%
Shares held by institutions	23.17%
Shares outstanding	12.6M
Short % of float	4.47%
Short % of shares	2.97%
Short ratio	2.5 days

Deeper analysis on NRXS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NRXS report

Is a complete NRXS research report available?

No complete published report is available for NeurAxis, Inc. (NRXS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NeurAxis, Inc. (NRXS)

Price

Financial snapshot

Fair-value bridge

Latest news · NRXS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NRXS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NRXS

Frequently asked questions